Melatonin and Its Effect on the Perioperative Opioid Needs in Pediatric Patients Undergoing Laparoscopic Surgery.
NCT ID: NCT05728892
Last Updated: 2024-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
72 participants
INTERVENTIONAL
2023-01-25
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Melatonin on Postoperative Pain After Simple Nephrectomy
NCT06872944
Melatonin in Obese Patients in Laparoscopic Cholecystectomy
NCT06355687
Analgesic and Antioxidant Effects of Melatonin in Pediatric Surgery
NCT06724432
The Role of Preoperative Melatonin in Reducing the Inhaled Isoflurane Requirements in Open Nephrectomy
NCT04959825
Analgesic Effect of Melatonin and Vitamin C Administration, Alone or In Combination in Major Abdominal Surgery.
NCT06374771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
patients undergoing abdominal surgery receiving melatonin
Melatonin 3 MG
Preopertive melatonin adminstration oral 0.2 mg /kg 45 min before general anaethesia.
Group B
control group
Placebo
Placebo medication will be given to control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Melatonin 3 MG
Preopertive melatonin adminstration oral 0.2 mg /kg 45 min before general anaethesia.
Placebo
Placebo medication will be given to control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sex: Both sexes.
* Patients with ASA classificaion I and II.
Exclusion Criteria
* History of allergy to the medications used in the study.
* psychiatric disorder.
* ASA classification III-V.
* Fever ,cough , asthma or upper respiratory tract infection, neuromuscular disorders, spine abnormalities.
* Anticipated difficult airway .
* History of malignant hyperthermia
2 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain shams university hospital
Cairo, Abbasia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Diaaeldein M Haiba
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sherif Wadei, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAMSU R264/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.